|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/20 Concord Medical Svcs Holdings Ltd 20-F 12/31/19 164:22M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual Report by a Foreign Non-Canadian Issuer HTML 1.69M
2: EX-2.4 Plan of Acquisition, Reorganization, Arrangement, HTML 102K
Liquidation or Succession
3: EX-8.1 Opinion of Counsel re: Tax Matters HTML 44K
6: EX-13.1 Annual or Quarterly Report to Security Holders HTML 44K
7: EX-13.2 Annual or Quarterly Report to Security Holders HTML 43K
4: EX-12.1 Statement re: Computation of Ratios HTML 49K
5: EX-12.2 Statement re: Computation of Ratios HTML 49K
8: EX-15.1 Letter re: Unaudited Interim Financial Info HTML 42K
69: R1 Document and Entity Information HTML 82K
135: R2 Consolidated Balance Sheets HTML 199K
115: R3 Consolidated Balance Sheets (Parenthetical) HTML 85K
21: R4 Consolidated Statements of Comprehensive Loss HTML 145K
74: R5 Consolidated Statements of Comprehensive Loss HTML 48K
(Parenthetical)
140: R6 Consolidated Statements of Cash Flows HTML 248K
120: R7 Consolidated Statements of Shareholders' Equity HTML 112K
15: R8 Organization and Basis of Presentation HTML 349K
75: R9 Summary of Significant Accounting Policies HTML 220K
18: R10 Concentration of Risks HTML 55K
71: R11 Acquisitions and Disposals HTML 180K
136: R12 Short Term Investment HTML 47K
116: R13 Accounts Receivable HTML 97K
20: R14 Prepayments and Other Current Assets HTML 115K
73: R15 Inventories HTML 75K
138: R16 Assets Held for Sale HTML 46K
118: R17 Property, Plant and Equipment, Net HTML 86K
16: R18 Lease HTML 299K
76: R19 Goodwill HTML 71K
158: R20 Intangible Assets, Net HTML 189K
103: R21 Deposits for Non-Current Assets HTML 64K
47: R22 Long-Term Investments HTML 131K
65: R23 Other Non-Current Assets HTML 71K
160: R24 Accrued Expenses and Other Liabilities HTML 84K
105: R25 Shareholders' Equity HTML 49K
49: R26 Bank and Other Borrowings HTML 92K
67: R27 Restricted Net Assets HTML 49K
161: R28 Taxation HTML 302K
101: R29 Share-Based Awards HTML 179K
112: R30 Revenue HTML 111K
132: R31 Related Party Transactions HTML 265K
80: R32 Employee Defined Contribution Plan HTML 48K
26: R33 Commitments and Contingencies HTML 47K
110: R34 Segment Reporting HTML 168K
130: R35 Loss Per Share HTML 121K
78: R36 Fair Value Measurements HTML 165K
24: R37 Parent Company Only Condensed Financial HTML 232K
Information
114: R38 Subsequent Events HTML 47K
129: R39 Summary of Significant Accounting Policies HTML 318K
(Policies)
98: R40 Organization and Basis of Presentation (Tables) HTML 338K
155: R41 Summary of Significant Accounting Policies HTML 203K
(Tables)
55: R42 Acquisitions and Disposals (Tables) HTML 182K
38: R43 Accounts Receivable (Tables) HTML 96K
96: R44 Prepayments and Other Current Assets (Tables) HTML 115K
153: R45 Inventories (Tables) HTML 76K
53: R46 Property, Plant and Equipment, Net (Tables) HTML 82K
36: R47 Lease (Tables) HTML 307K
100: R48 Goodwill (Tables) HTML 70K
152: R49 Intangible Assets, Net (Tables) HTML 192K
145: R50 Deposits for Non-Current Assets (Tables) HTML 63K
127: R51 Long-Term Investments (Tables) HTML 132K
27: R52 Other Non-Current Assets (Tables) HTML 71K
82: R53 Accrued Expenses and Other Liabilities (Tables) HTML 84K
146: R54 Bank and Other Borrowings (Tables) HTML 93K
128: R55 Taxation (Tables) HTML 302K
28: R56 Share-Based Awards (Tables) HTML 181K
84: R57 Revenue (Tables) HTML 110K
147: R58 Related Party Transactions (Tables) HTML 251K
126: R59 Segment Reporting (Tables) HTML 173K
41: R60 Loss Per Share (Tables) HTML 121K
56: R61 Fair Value Measurements (Tables) HTML 160K
148: R62 Parent Company Only Condensed Financial HTML 233K
Information (Tables)
91: R63 Organization and Basis of Presentation (Schedule HTML 132K
of Subsidiaries) (Details)
44: R64 Organization and Basis of Presentation (Schedule HTML 163K
of financial information) (Details)
59: R65 Organization and Basis of Presentation (Narrative) HTML 280K
(Details)
151: R66 Summary of Significant Accounting Policies HTML 57K
(Schedule of Information Relating to Property,
Plant and Equipment) (Details)
95: R67 Summary of Significant Accounting Policies HTML 60K
(Schedule of estimated useful life for the
intangible assets) (Details)
39: R68 Summary of Significant Accounting Policies HTML 48K
(Summary of revenue recognized) (Details)
60: R69 Summary of Significant Accounting Policies HTML 62K
(Adoption of ASU) (Details)
90: R70 Summary of Significant Accounting Policies - HTML 71K
Adoption of ASU-842 (Details)
32: R71 Summary of Significant Accounting Policies HTML 101K
(Narrative) (Details)
125: R72 Concentration of Risks (Narrative) (Details) HTML 57K
144: R73 Acquisitions and Disposals (Schedule of Assets and HTML 62K
Liabilities of Beijing Century Friendship and
Bpmc) (Details)
87: R74 Acquisitions and Disposals (Schedule of Gain HTML 48K
Realized on Deemed Disposal) (Details)
29: R75 Acquisitions and Disposals (Schedule of purchase HTML 101K
price as of the date of acquisition) (Details)
122: R76 Acquisitions and Disposals (Schedule of Pro forma HTML 53K
Results) (Details)
141: R77 Acquisitions and Disposals (Schedule of Actual HTML 53K
Results from Acquisition Date) (Details)
86: R78 Acquisitions and Disposals (Narrative) (Details) HTML 208K
34: R79 Short Term Investment (Debt Investment) (Details) HTML 50K
89: R80 Accounts Receivable (Schedule of Accounts HTML 68K
Receivable) (Details)
31: R81 Accounts Receivable (Narrative) (Details) HTML 45K
124: R82 Prepayments and Other Current Assets (Schedule of HTML 75K
Prepayments and Other Current Assets) (Details)
143: R83 Prepayments and Other Current Assets (Narrative) HTML 61K
(Details)
88: R84 Inventories (Schedule of Inventory) (Details) HTML 59K
30: R85 Assets Held for Sale (Narrative) (Details) HTML 45K
123: R86 Property, Plant and Equipment, Net (Schedule of HTML 72K
Property Plant and Equipment Net) (Details)
142: R87 Property, Plant and Equipment, Net - (Narrative) HTML 67K
(Details)
85: R88 Lease (Narrative) (Details) HTML 88K
33: R89 Lease (Lease receivables) (Details) HTML 54K
42: R90 Lease (Net investment in direct financing leases) HTML 56K
(Details)
57: R91 Lease (Summary of non-cancelable direct financing HTML 55K
leases) (Details)
149: R92 Lease (Schedule of Prepaid Land Lease Payments) HTML 56K
(Details)
93: R93 Lease (Other operating leases) (Details) HTML 50K
43: R94 Lease (Other information) (Details) HTML 53K
58: R95 Lease (Summary of future lease payments) (Details) HTML 62K
150: R96 Lease (Schedule of Estimated Annual Amortization HTML 51K
Expenses) (Details)
94: R97 Lease (Lease income) (Details) HTML 57K
40: R98 Lease ( Schedule of Non-cancellable Operating HTML 56K
Lease Payment) (Details)
61: R99 Goodwill (Carrying Amount) (Details) HTML 48K
162: R100 Goodwill (Narrative) (Details) HTML 49K
108: R101 Intangible Assets, Net (Schedule of Acquired HTML 101K
Intangible Assets) (Details)
45: R102 Intangible Assets, Net (Schedule of Estimated HTML 55K
Annual Amortization Expenses) (Details)
62: R103 Intangible Assets, Net (Narrative) (Details) HTML 52K
163: R104 Deposits for Non-Current Assets (Schedule of HTML 50K
Deposits for Non-Current Assets) (Details)
109: R105 Deposits for Non-Current Assets (Schedule of HTML 59K
Deposits for Non-Current Assets) (Narrative)
(Details)
46: R106 Long-Term Investments (Details) HTML 51K
63: R107 Long-Term Investments (Details 1) HTML 48K
164: R108 Long-Term Investments (Schedule of Equity Method HTML 69K
Investments) (Details 2)
107: R109 Long-Term Investments (Narrative) (Details) HTML 193K
119: R110 Other Non-Current Assets (Schedule of Other HTML 56K
Non-Current Assets) (Details)
139: R111 Other Non-Current Assets (Narrative) (Details) HTML 46K
72: R112 Accrued Expenses and Other Liabilities (Schedule HTML 72K
of Accrued Expenses and Other Liabilities)
(Details)
19: R113 Shareholders' Equity (Narrative) (Details) HTML 72K
117: R114 Bank and Other Borrowings (Schedule of Bank and HTML 55K
Other Borrowings) (Details)
137: R115 Bank and Other Borrowings (Schedule of Maturities HTML 62K
of Long-Term and Other Debt) (Details)
70: R116 Bank and Other Borrowings (Narrative) (Details) HTML 84K
17: R117 Restricted Net Assets (Narrative) (Details) HTML 54K
121: R118 Taxation (Narrative) (Details) HTML 100K
134: R119 Taxation (Schedule of (Loss) Income from HTML 51K
Continuing Operations Before Income Taxes)
(Details)
68: R120 Taxation (Schedule of Income Tax Expense from HTML 53K
Continuing Operations) (Details)
50: R121 Taxation (Reconciliation of Differences Between HTML 82K
Statutory Tax Rate and Effective Tax Rate)
(Details)
104: R122 Taxation (Reconciliation of Differences Between HTML 46K
Statutory Tax Rate and Effective Tax Rate)
(Parenthetical) (Details)
159: R123 Taxation (Schedule of Deferred Taxes) (Details) HTML 120K
66: R124 Taxation (Schedule of Movement of Valuation HTML 47K
Allowance) (Details)
48: R125 Taxation (Reconciliation of Accrued Unrecognized HTML 58K
Tax Positions) (Details)
102: R126 Share-Based Awards (Narrative) (Details) HTML 68K
157: R127 Share-Based Awards (Schedule of Assumptions Used) HTML 52K
(Details)
64: R128 Share-Based Awards (Schedule of Stock Options) HTML 91K
(Details)
51: R129 Share-Based Awards (Summary of Restricted Shares) HTML 112K
(Details)
23: R130 Share-Based Awards (Schedule of Share-Based HTML 52K
Compensation Expense) (Details)
77: R131 Revenue (Details) HTML 73K
131: R132 Related Party Transactions (Schedule of Related HTML 100K
Party Transactions) (Details)
111: R133 Related Party Transactions (Schedule of Related HTML 74K
Party Balances) (Details)
25: R134 Employee Defined Contribution Plan (Narrative) HTML 51K
(Details)
79: R135 Commitments and Contingencies (Narrative) HTML 49K
(Details)
133: R136 Segment Reporting (Narrative) (Details) HTML 50K
113: R137 Segment Reporting (Schedule of Segment HTML 67K
Information) (Details)
22: R138 Segment Reporting (Schdeule of Net Revenue by HTML 51K
Country based upon Sales Location that
Predominately represents Customer Location)
(Details)
81: R139 Segment Reporting (Schdeule of Total Long-Lived HTML 50K
Assets excluding Financial Instruments, Intangible
Assets and Deferred Tax Assets by Country)
(Details)
35: R140 Loss Per Share (Schedule of Basic and Diluted HTML 69K
Income Per Share) (Details)
52: R141 Fair Value Measurements (Schedule of Fair Value HTML 68K
Measurements for Each Class of Assets on
Nonrecurring Basis) (Details)
154: R142 Fair Value Measurements (Narrative) (Details) HTML 51K
97: R143 Parent Company Only Condensed Financial HTML 121K
Information (Condensed balance Sheets) (Details)
37: R144 Parent Company Only Condensed Financial HTML 67K
Information (Condensed balance Sheets)
(Parenthetical) (Details)
54: R145 Parent Company Only Condensed Financial HTML 90K
Information (Condensed statements of comprehensive
loss) (Details)
156: R146 Parent Company Only Condensed Financial HTML 64K
Information (Condensed statements of cash flows)
(Details)
99: R147 Subsequent Events (Narrative) (Details) HTML 57K
83: XML IDEA XML File -- Filing Summary XML 327K
106: EXCEL IDEA Workbook of Financial Reports XLSX 210K
9: EX-101.INS XBRL Instance -- ccm-20191231 XML 7.89M
11: EX-101.CAL XBRL Calculations -- ccm-20191231_cal XML 369K
12: EX-101.DEF XBRL Definitions -- ccm-20191231_def XML 1.28M
13: EX-101.LAB XBRL Labels -- ccm-20191231_lab XML 2.38M
14: EX-101.PRE XBRL Presentations -- ccm-20191231_pre XML 2.13M
10: EX-101.SCH XBRL Schema -- ccm-20191231 XSD 410K
92: ZIP XBRL Zipped Folder -- 0001104659-20-054484-xbrl Zip 441K
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-222559) pertaining to the 2008 Share Incentive Plan of Concord Medical Services Holdings Limited of our reports dated April 30, 2020, with respect to the consolidated financial statements of Concord Medical Services Holdings Limited and the effectiveness of internal control over financial reporting of Concord Medical Services Holdings Limited included in this Annual Report (Form 20-F) for the year ended December 31, 2019, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young Hua Ming LLP | ||
| Shenzhen, People’s Republic of China | ||
| April 30, 2020 |
C:
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/19/24 Concord Medical Svcs Holdings Ltd 20-F 12/31/23 166:21M Toppan Merrill/FA 4/19/23 Concord Medical Svcs Holdings Ltd 20-F 12/31/22 170:22M Toppan Merrill/FA2 4/29/22 Concord Medical Svcs Holdings Ltd 20-F 12/31/21 170:23M Toppan Merrill/FA2 10/15/21 Concord Medical Svcs Holdings Ltd 20-F 12/31/20 166:22M Toppan Merrill/FA |